AlphaCentric Advisors’s AdaptHealth AHCO Stock Holding History

AlphaCentric Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-282,500	Closed	-$3.44M	–	236
2023 Q2	$3.44M	Buy	282,500 +166,000	+142%	+$1.85M	1.91%	8
2023 Q1	$1.45M	Buy	+116,500	New	+$2.14M	1%	25
2021 Q4	$770K	Buy	31,500 +3,500	+13%	+$82.2K	0.22%	45
2021 Q3	$652K	Buy	28,000 +10,000	+56%	+$242K	0.17%	55
2021 Q2	$493K	Buy	+18,000	New	+$513K	0.13%	63

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

AlphaCentric Advisors's AHCO Position: Q3 2023 in Review

AlphaCentric Advisors sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 282,500 shares — an estimated $3.44M sold.

AlphaCentric Advisors first reported a position in AHCO in Q2 2021 and held it in 5 quarters. The position peaked at $3.44M in Q2 2023. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

AlphaCentric Advisors reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
AlphaCentric Advisors sold 282,500 AdaptHealth shares in Q3 2023, an estimated $3.44M.
AlphaCentric Advisors first reported a position in AdaptHealth in Q2 2021 and held it in 5 quarters.
AlphaCentric Advisors's AdaptHealth position peaked at $3.44M in Q2 2023.
191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.